Benefit of Rusfertide Maintained in Patients (Pts) With Low-Risk or High-Risk Polycythemia Vera (PV): Efficacy and Safety Subgroup Analysis From the Randomized Controlled Phase 3 VERIFY Study

Impact of Rusfertide on Polycythemia Vera (PV)-Related Symptoms and Patient-Reported Outcome-Related Items in the Randomized, Double-Blind Phase 3 VERIFY Study

Effect of Rusfertide on Cytoreductive Therapy Use in Patients with Phlebotomy Dependent Polycythemia Vera: Post Hoc Analysis from the Randomized Controlled Phase 3 VERIFY Study

Thromboembolic and Progression Events in Phlebotomy-Dependent Patients with Polycythemia Vera (PV): Long-Term Results From the Phase 2 REVIVE and THRIVE Open-Label Extension Rusfertide Studies